Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by Buckshot26on Mar 08, 2018 2:47pm

209 Views

Post# 27685527

RE:RE:RE:RE:RE:RE:Vic knows what he's doing. Time is of the essence.

sorry meant to include a link to the awards.

2017 AWARDS

Buckshot26 wrote: If you don't get that the goal is to be bought out before the massive $50to 150billion conglomerates move in I really can't help you. To each their own I guess.

I see that you are correct, they did manage a third place in ONE category.

I also see that LEAF was rated top LP overall.

Both companies were licensed one month apart.

One decided growing good mj was most important the other decided growing their share count was.

As I keep saying, at some point selling this stuff is going to matter most.

Regards.

BaconIsBad wrote:
Aphria has won awards for their CBD oil, as well as Broken Coast.

If you remember correctly, Health Canada's delay prevented Aphria from reaching their full revenue potential last quarter.

LEAF is valued 2/3 of APH because they do not come close to their international presence, supply deals, or current/future capacity.

I didn't realize that the goal here was to get bought out by Big Pharma/Tobacco/Alcohol before massive revenues kick in. Silly me.

Remember a few months ago when you were seriously considering selling all of your shares because you were upset with the direction management was going, and then you woke up to APH acquiring Broken Coast and forgot about your troubles real fast? Just chill out.

Sometimes, the market is asleep. Stay woke.

Buckshot26 wrote: why are you attributing 100% of the DD yield to APH?

LEAF wins award after award for the product they grow, APH can't claim a single award. At some point selling this stuff will trump over growing it right bud-light drinkers :)

LEAF and APH got their initial licenses in spring 2014 yet LEAF sold $11.35million last qtr while APH only did $8.5million.

LEAF is valued roughly at two thirds of APH.

LEAF gets bought out before APH in my opinio as it is clean of the US mess, cheaper and grows superior product.

kenster wrote: Aph vrs Leaf, Aph is expected to have 220,000 kgs for sale Jan 2019 at lowest cost per gram and a
25% discount price to Leaf Leaf still needs to close,retrofit and get a new license.l'll Stick with Vic